Documented Substance Use and Prescription Records
Court filings and studio medical files show Judy Garland was prescribed amphetamines and barbiturates by multiple physicians from the 1940s onward. MGM studios routinely provided pills to keep performers on demanding schedules, and Garland's medical charts list doses of amphetamine salts and sedatives tied to weight control and sleep management pharmaceutical industry practices. Public biographies note that these prescriptions continued through her concert tours and film work, contributing to a pattern of dependence that became part of her public record.
Biographers and historians have cited studio memos and personal diaries that describe Garland's daily pill regimen, including stimulants for energy and sedatives for sleep. The frequency of these prescriptions is documented in letters and medical notes that reference dosages, refill dates, and physician names SEC filings related to entertainment companies. These records support a factual timeline of substance use that aligns with the pressures of the studio system and touring schedule.
Financial and Career Impact
Garland's substance use affected her earnings, contract negotiations, and studio relationships. MGM reduced her roles and withheld payments during periods of instability, while concert promoters sometimes canceled appearances due to reliability concerns. Court documents and contract disputes reference missed performances and additional costs tied to medical care and management changes pharmaceutical industry practices.
Later in her career, Garland's financial situation was shaped by legal fees, unpaid taxes, and settlement costs linked to personal and professional turmoil. Public records show multiple bankruptcy filings and liens, with expenses related to medical treatment and management of substance use cited as contributing factors SEC filings related to entertainment companies. These financial impacts are documented in bankruptcy court records and biographical accounts that track income, debt, and asset sales over time.
Regulatory and Cultural Context
Regulatory changes in the 1970s tightened control over prescription drugs and publicized the risks of amphetamine and barbiturate misuse. Garland's case is referenced in discussions about how entertainment industry practices intersected with emerging drug policy pharmaceutical industry practices. Public health campaigns and media coverage during that era drew attention to the broader pattern of prescription drug use among performers and executives.
Today, Garland's substance use is studied as part of the cultural history of Hollywood and the music industry, with archives and documentaries presenting verified records and expert analysis. Institutions and researchers cite studio files, court documents, and medical records to explain how systemic practices shaped individual outcomes SEC filings related to entertainment companies. The factual record underscores the connection between industry norms, prescription practices, and long-term health and financial consequences.